Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse - PubMed (original) (raw)
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse
Karen M Tordjman et al. Hypertension. 2007 Nov.
Abstract
Peroxisome proliferator-activated receptor-alpha is widely distributed in the vasculature where it is believed to exert pleiotropic antiatherogenic effects. Its role in the regulation of blood pressure is still unresolved; however, some evidence suggests that it may affect the renin-angiotensin system. We investigated its role in angiotensin II-induced hypertension in the Tsukuba hypertensive mouse (THM). This is a model of hypertension and atherosclerosis because of high angiotensin II and aldosterone levels as a result of the transgenic expression of the entire human renin-angiotensin system. Making the THM animals deficient in Peroxisome proliferator-activated receptor-alpha (THM/PPARKO) totally abolished hypertension and myocardial hypertrophy. This was accompanied by a reduction in plasma human active renin in THM/PPARKO mice compared with THM animals from 3525+/-128 mU/L to 1910+/-750 mU/L (P<0.05) and by a normalization of serum aldosterone (1.6+/-0.29 nmol/L versus 3.4+/-0.69 nmol/L; P=0.003). In the THM/PPARKO mice, the extent of atherosclerosis at the aortic sinus after a 12-week period on an atherogenic diet was decreased by >80%. In addition, the spontaneous formation of foam cells from peritoneal macrophages, a blood pressure-independent event, was reduced by 92% in the THM/PPARKO mice, suggesting protection from the usual oxidative stress in these animals, possibly because of lower prevailing angiotensin II levels. Finally, chronic fenofibrate treatment further elevated blood pressure in THM animals but not in THM/PPARKO animals. Taken together, these data indicate that peroxisome proliferator-activated receptor-alpha may regulate the renin-angiotensin system. They raise the possibility that its activation may aggravate hypertension and hasten atherosclerosis in the context of an activated renin-angiotensin system.
Comment in
- Peroxisome proliferator-activated receptor alpha: friend or foe?
Yagil C, Yagil Y. Yagil C, et al. Hypertension. 2007 Nov;50(5):847-50. doi: 10.1161/HYPERTENSIONAHA.107.100461. Epub 2007 Oct 1. Hypertension. 2007. PMID: 17909117 No abstract available.
Similar articles
- Peroxisome proliferator-activated receptor alpha: friend or foe?
Yagil C, Yagil Y. Yagil C, et al. Hypertension. 2007 Nov;50(5):847-50. doi: 10.1161/HYPERTENSIONAHA.107.100461. Epub 2007 Oct 1. Hypertension. 2007. PMID: 17909117 No abstract available. - Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.
Sugiyama F, Haraoka S, Watanabe T, Shiota N, Taniguchi K, Ueno Y, Tanimoto K, Murakami K, Fukamizu A, Yagami K. Sugiyama F, et al. Lab Invest. 1997 Jun;76(6):835-42. Lab Invest. 1997. PMID: 9194859 - Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II.
Nishijo N, Sugiyama F, Kimoto K, Taniguchi K, Murakami K, Suzuki S, Fukamizu A, Yagami K. Nishijo N, et al. Lab Invest. 1998 Sep;78(9):1059-66. Lab Invest. 1998. PMID: 9759650 - [Angiotensin and arteriosclerosis: an approach from transgenic and knockout mice].
Fukamizu A. Fukamizu A. Nihon Rinsho. 1999 May;57(5):1176-81. Nihon Rinsho. 1999. PMID: 10361452 Review. Japanese. - Activated and inactivated renin-angiotensin system in transgenic animals: from genes to blood pressure.
Fukamizu A, Murakami K. Fukamizu A, et al. Lab Anim Sci. 1997 Apr;47(2):127-31. Lab Anim Sci. 1997. PMID: 9150489 Review.
Cited by
- Anti-Hypertensive Action of Fenofibrate via UCP2 Upregulation Mediated by PPAR Activation in Baroreflex Afferent Pathway.
Guan J, Zhao M, He C, Li X, Li Y, Sun J, Wang W, Cui YL, Zhang Q, Li BY, Qiao GF. Guan J, et al. Neurosci Bull. 2019 Feb;35(1):15-24. doi: 10.1007/s12264-018-0271-1. Epub 2018 Sep 1. Neurosci Bull. 2019. PMID: 30173356 Free PMC article. - Oxidative stress promotes myocardial fibrosis by upregulating KCa3.1 channel expression in AGT-REN double transgenic hypertensive mice.
Wang LP, Fan SJ, Li SM, Wang XJ, Gao JL, Yang XH. Wang LP, et al. Pflugers Arch. 2017 Sep;469(9):1061-1071. doi: 10.1007/s00424-017-1984-0. Epub 2017 Apr 28. Pflugers Arch. 2017. PMID: 28455747 - PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1.
Wang W, Fang Q, Zhang Z, Wang D, Wu L, Wang Y. Wang W, et al. Front Pharmacol. 2020 Oct 8;11:528267. doi: 10.3389/fphar.2020.528267. eCollection 2020. Front Pharmacol. 2020. PMID: 33132907 Free PMC article. - Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Lalloyer F, Wouters K, Baron M, Caron S, Vallez E, Vanhoutte J, Baugé E, Shiri-Sverdlov R, Hofker M, Staels B, Tailleux A. Lalloyer F, et al. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1573-9. doi: 10.1161/ATVBAHA.110.220525. Epub 2011 Apr 7. Arterioscler Thromb Vasc Biol. 2011. PMID: 21474829 Free PMC article. - Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction.
Chew GT, Watts GF, Davis TM, Stuckey BG, Beilin LJ, Thompson PL, Burke V, Currie PJ. Chew GT, et al. Diabetes Care. 2008 Aug;31(8):1502-9. doi: 10.2337/dc08-0118. Epub 2008 May 16. Diabetes Care. 2008. PMID: 18487480 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials